IPO registrations (S-1, F-1) · Underwriters
ING
- Deals
- 22 priced offerings as an underwriter, 13 as lead manager or representative; 21 initial public offerings
- Proceeds of those deals
- $94,498,402,058 ($77,454,311,861 as lead)
- Years
- 2021–2026
- Named in
- 44 prospectuses and registration statements in all, including offerings not yet priced or withdrawn
Deals by year
| Year | Deals | As lead | Proceeds of deals |
|---|---|---|---|
| 2026 | 3 | 2 | $75,979,795,349 |
| 2025 | 6 | 3 | $8,640,599,978 |
| 2023 | 5 | 2 | $6,879,209,795 |
| 2022 | 2 | 1 | $1,699,999,998 |
| 2021 | 6 | 5 | $1,298,796,938 |
Deals 26
| Priced | Company | Role | Price | Range | Shares | Proceeds | Listing | Kind | Syndicate | Prospectus |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-30 | BHAV Acquisition Corp II | Lead | $10.00 | 10,000,000 | $100,000,000 | Nasdaq BHAIU | IPO | 2 | 424B4 ↗ | |
| 2026-06-12 | SPACE EXPLORATION TECHNOLOGIES CORP TX | Lead | $135.00 | 555,555,555 | $74,999,999,925 | Nasdaq SPCX | IPO | 22 | 424B4 ↗ | |
| 2026-03-12 | PayPay Corp | Syndicate | $16.00 | 54,987,214 | $879,795,424 | Nasdaq PAYP | IPO | 21 | 424B4 ↗ | |
| 2025-12-18 | Medline Inc. IL | Syndicate | $29.00 | 216,034,482 | $6,264,999,978 | Nasdaq MDLN | IPO | 52 | 424B4 ↗ | |
| 2025-10-01 | StoneBridge Acquisition II Corp NY | Lead | $10.00 | 5,000,000 | $50,000,000 | Nasdaq APAC | IPO | 2 | 424B4 ↗ | |
| 2025-08-08 | ETOILES CAPITAL GROUP CO., LTD | Lead | $4.00 | 1,400,000 | $5,600,000 | EFTY | IPO | 3 | 424B4 ↗ | |
| 2025-07-03 | EQV Ventures Acquisition Corp. II UT | Lead | $10.00 | 42,000,000 | $420,000,000 | NYSE EVAC | IPO | 2 | 424B4 ↗ | |
| 2025-06-27 | Jefferson Capital, Inc. / DE MN | Syndicate | $15.00 | 10,000,000 | $150,000,000 | Nasdaq JCAP | IPO | 11 | 424B4 ↗ | |
| 2025-01-24 | Venture Global, Inc. VA | Syndicate | $25.00 | 70,000,000 | $1,750,000,000 | NYSE VG | IPO | 20 | 424B4 ↗ | |
| 2023-09-18 | Neumora Therapeutics, Inc. MA | Lead | $17.00 | 14,710,000 | $250,070,000 | Nasdaq NMRA | IPO | 7 | 424B4 ↗ | |
| 2023-06-08 | GE HealthCare Technologies Inc. IL | Syndicate | $76.54 | 25,000,000 | $1,913,437,500 | Nasdaq GEHC | Offering | 23 | 424B4 ↗ | |
| 2023-05-26 | Atmus Filtration Technologies Inc. TN | Syndicate | $19.50 | 14,124,409 | $275,425,975 | NYSE ATMU | IPO | 12 | 424B4 ↗ | |
| 2023-05-04 | Kenvue Inc. NJ | Syndicate | $22.00 | 172,812,560 | $3,801,876,320 | NYSE KVUE | IPO | 20 | 424B4 ↗ | |
| 2023-02-10 | Nextpower Inc. CA | Lead | $24.00 | 26,600,000 | $638,400,000 | Nasdaq NXT | IPO | 17 | 424B4 ↗ | |
| 2022-09-16 | Corebridge Financial, Inc. TX | Syndicate | $21.00 | 80,000,000 | $1,680,000,000 | NYSE CRBG | IPO | 41 | 424B4 ↗ | |
| 2022-02-23 | Onconetix, Inc. OH | Lead | $9.00 | 2,222,222 | $19,999,998 | Nasdaq BWV | IPO | 2 | 424B4 ↗ | |
| 2021-11-05 | Arhaus, Inc. OH | Lead | $13.00 | 12,903,226 | $167,741,938 | Nasdaq ARHS | IPO | 14 | 424B4 ↗ | |
| 2021-10-15 | Rubicon Technologies, Inc. KY | Lead | $10.00 | 27,500,000 | $275,000,000 | Nasdaq FOUN | IPO | 4 | 424B4 ↗ | |
| 2021-09-24 | Sterling Check Corp. OH | Syndicate | $23.00 | 14,285,000 | $328,555,000 | Nasdaq STER | IPO | 10 | 424B4 ↗ | |
| 2021-07-30 | RISKIFIED LTD. NY | Lead | $21.00 | 17,500,000 | $367,500,000 | NYSE RSKD | IPO | 13 | 424B4 ↗ | |
| 2021-07-23 | Teads Holding Co. NY | Lead | $20.00 | 8,000,000 | $160,000,000 | Nasdaq OB | IPO | 8 | 424B4 ↗ | |
| 2021-03-05 | FTAC Hera Acquisition Corp. PA | Lead | $10.00 | - | - | Nasdaq HERA | IPO | 3 | 424B4 ↗ | |
| 2021-01-29 | Ortho Clinical Diagnostics Holdings plc NJ | Syndicate | $17.00 | 76,000,000 | $1,292,000,000 | Nasdaq OCDX | IPO | 18 | 424B4 ↗ | |
| 2021-01-22 | European Sustainable Growth Acquisition Corp. CT | Lead | $1.00 | 12,500,000 | $12,500,000 | Nasdaq EUSG | IPO | 3 | 424B4 ↗ | |
| 2020-12-09 | Mudrick Capital Acquisition Corp. II NY | Lead | $10.00 | 27,500,000 | $275,000,000 | Nasdaq MUDS | IPO | 2 | 424B4 ↗ | |
| 2020-11-23 | Sotera Health Co OH | Syndicate | $23.00 | 46,600,000 | $1,071,800,000 | Nasdaq SHC | IPO | 16 | 424B4 ↗ |
“Offering” is a priced registered offering that the cover page does not describe as an initial public offering: a follow-on, a resale, or a small company’s best-efforts deal.
Registrations in progress or never priced 2
| Filed | Company | Role | Range | Shares | Listing | Status | Document |
|---|---|---|---|---|---|---|---|
| 2021-01-19 | Ortho Clinical Diagnostics Holdings plc | Syndicate | $20.00–$23.00 | 70,000,000 | Nasdaq OCDX | Priced 2021-01-29 (terms not read) | S-1/A ↗ |
| 2020-11-18 | Sotera Health Co | Syndicate | $20.00–$23.00 | 46,600,000 | Nasdaq SHC | Priced 2020-11-23 (terms not read) | S-1/A ↗ |
Works alongside
| Firm | Deals together | Of which that firm led |
|---|---|---|
| J.P. Morgan | 15 | 13 |
| BofA Securities | 12 | 8 |
| Goldman Sachs | 12 | 10 |
| Citigroup | 11 | 4 |
| Barclays | 10 | 1 |
| Jefferies | 9 | 6 |
| Morgan Stanley | 8 | 4 |
| Siebert Williams Shank | 8 | 0 |
| Deutsche Bank | 7 | 0 |
| Mizuho | 7 | 1 |
| Ramirez & Co. | 7 | 0 |
| Santander | 7 | 0 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Offering terms are read from the cover pages of the registrant's final prospectus (424B4, 424B1) and its latest registration statement before pricing: the price range, the final price, shares offered, gross proceeds (the cover's total, else price times shares), exchange and ticker, and the underwriters named on the cover and in the underwriting table (loader/s1_terms.py). Underwriter names are normalised, so Goldman, Sachs & Co. of 1999 and Goldman Sachs & Co. LLC of 2024 are one firm.